Alliance for Cannabis Therapeutics

Last updated
Alliance for Cannabis Therapeutics (ACT)
Formation1981
PurposeMedical Marijuana Legalization
Leader Robert Randall

The Alliance for Cannabis Therapeutics (ACT) is an organization supporting medical marijuana that was founded in 1981 by Robert C. Randall and Alice O'Leary. [1] Randall was the first person known to have successfully used medical necessity as a defense against a charge of marijuana possession in violation of the Controlled Substances Act. [2]

Contents

History

Clare Hodges aka Elizabeth Brice founded the Alliance for Cannabis Therapeutics (ACT) in the UK after contacting the Alice O'Leary and Robert Randall in 1992 about the medical benefits of marijuana for individuals suffering from multiple sclerosis. [3]

The group participated in the 1986 hearings on cannabis rescheduling in the United States. ACT along with NORML petitioned for review of the final order of the Administrator of the Drug Enforcement Administration which followed the hearings. See Alliance for Cannabis Therapeutics v. DEA, 930 F.2d 936 (D.C.Cir.1991) [4]

Related Research Articles

<span class="mw-page-title-main">Marihuana Tax Act of 1937</span> American law placing a tax on cannabis

The Marihuana Tax Act of 1937, Pub. L. 75–238, 50 Stat. 551, enacted August 2, 1937, was a United States Act that placed a tax on the sale of cannabis. The H.R. 6385 act was drafted by Harry Anslinger and introduced by Rep. Robert L. Doughton of North Carolina, on April 14, 1937. The Seventy-fifth United States Congress held hearings on April 27, 28, 29th, 30th, and May 4, 1937. Upon the congressional hearings confirmation, the H.R. 6385 act was redrafted as H.R. 6906 and introduced with House Report 792. The Act is now commonly referred to, using the modern spelling, as the 1937 Marijuana Tax Act. This act was overturned in 1969 in Leary v. United States, and was repealed by Congress the next year.

<span class="mw-page-title-main">1996 California Proposition 215</span> California law permitting medical marijuana

Proposition 215, or the Compassionate Use Act of 1996, is a California law permitting the use of medical cannabis despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy. It was enacted, on November 5, 1996, by means of the initiative process, and passed with 5,382,915 (55.6%) votes in favor and 4,301,960 (44.4%) against.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is an American nonprofit organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin and is now based in San Jose, California.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category is the most tightly restricted category reserved for drugs that have "no currently accepted medical use."

<span class="mw-page-title-main">Legalization of non-medical cannabis in the United States</span> Legalization of marijuana in the United States

In the United States, the non-medical use of cannabis is legalized in 23 states and decriminalized in 8 states, as of May 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

<span class="mw-page-title-main">Federal drug policy of the United States</span> Nationwide framework regarding the abuse of drugs in the United States

The drug policy in the United States is the activity of the federal government relating to the regulation of drugs. Starting in the early 1900s the United States government began enforcing drug policies. These policies criminalized drugs such as opium, morphine, heroine, and cocaine outside of medical use. The drug policies put into place are enforced by the Food and Drug Administration and the Drug Enforcement Administration. Classification of Drugs are defined and enforced using the Controlled Substance Act, which lists different drugs into their respective substances based on its potential of abuse and potential for medical use. Four different categories of drugs are Alcohol, Cannabis, Opioids, and Stimulants.

<span class="mw-page-title-main">Cannabis in the United States</span> Legality, use, culture, market and production of cannabis in the United States

The use, sale, and possession of cannabis over 0.3% THC in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis over 0.3% THC is considered to have "no accepted medical use" and have a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.

<span class="mw-page-title-main">Cannabis in Oregon</span> Use of cannabis in Oregon

Cannabis in Oregon is legal for both medical and recreational use. In recent decades, the U.S. state of Oregon has had a number of legislative, legal, and cultural events surrounding use of cannabis. Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes. An attempt to recriminalize possession of small amounts of cannabis was turned down by Oregon voters in 1997.

<span class="mw-page-title-main">Medical cannabis in the United States</span> Use of cannabis for medical purposes in the United States

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

<span class="mw-page-title-main">Dronabinol</span> Generic name of Δ9-THC in medicine

The International Nonproprietary Name dronabinol, also known under the trade names Marinol, Syndros, Reduvo and Adversa, is a generic name for the molecule of delta-9-tetrahydrocannabinol in the pharmaceutical context. It has indications as an appetite stimulant, antiemetic, and sleep apnea reliever and is approved by the FDA as safe and effective for HIV/AIDS-induced anorexia and chemotherapy-induced nausea and vomiting only.

Wo/Men's Alliance for Medical Marijuana (WAMM) is a not-for-profit medicinal cannabis dispensing collective located in Santa Cruz, California. WAMM was founded in 1993 by Valerie Leveroni Corral and her then-husband Michael Corral. Valerie Corral is also the executive director of Raha Kudo: Design for Dying Project, a non-profit corporation that provides education and research to support persons facing death and their caregivers. Members of WAMM receive organic medicinal cannabis at cost while volunteers trade work for cannabis. There is a compassion program for those unable to afford the full cost of medical cannabis. WAMM was the first medical marijuana collective to receive non-profit status from the United States Government.

<span class="mw-page-title-main">Robert C. Randall</span> American cannabis rights activist

Robert C. Randall was an American advocate for medical marijuana and the founder of Alliance for Cannabis Therapeutics.

Gonzales v. Raich, 545 U.S. 1 (2005), was a decision by the U.S. Supreme Court ruling that under the Commerce Clause of the U.S. Constitution, Congress may criminalize the production and use of homegrown cannabis even if state law allows its use for medicinal purposes.

<span class="mw-page-title-main">Ending Federal Marijuana Prohibition Act</span>

The Ending Federal Marijuana Prohibition Act is a series of federal marijuana decriminalization bills that have been introduced multiple times in the United States Congress.

Americans for Safe Access v. Drug Enforcement Administration was a case in which the U.S. Court of Appeals for the D.C. Circuit held that the DEA's denial of a petition by plaintiff Americans for Safe Access for removal of cannabis from Schedule I of the Controlled Substances Act survives review under the deferential arbitrary and capricious standard. 21 U.S.C. § 812(b)(1)(B) requires that cannabis be found to have no "currently accepted medical use" in order to remain in Schedule I. This DEA, pursuant to regulations that the court had approved in Alliance for Cannabis Therapeutics v. DEA, interpreted this to require "adequate and well-controlled studies proving efficacy" in order for cannabis to be removed from Schedule I. The court deferred to the agency's interpretation and found that substantial evidence supported the DEA's determination that such studies do not exist. This case was the third attempt to get the D.C. Circuit to order that cannabis be rescheduled.

<span class="mw-page-title-main">Glossary of cannabis terms</span>

Terms related to cannabis include:

The International Association for Cannabinoid Medicines (IACM), formerly known as the International Association for Cannabis as a Medicine, is a non-profit scientific society founded in Cologne in 2000 and dedicated to the advancement of knowledge of cannabis and cannabinoid medicines among medical professionals. IACM is one of the few global non-profit medical societies or associations related to cannabis and Cannabinoids, along with the Society of Cannabis Clinicians and the International Cannabinoid Research Society.

References

  1. "Robert Randall, 53; Sued for Marijuana". New York Times. 2001-06-08. Retrieved 2011-04-20.
  2. "Archived copy" (PDF). Archived from the original (PDF) on 2009-02-05. Retrieved 2009-02-04.{{cite web}}: CS1 maint: archived copy as title (link)
  3. Rosner, Abbie. "A Conversation With Veteran Cannabis Activist Alice O'Leary Randall". Forbes. Retrieved 2023-08-19.
  4. "930 F.2d 936: Alliance for Cannabis Therapeutics, Petitioner, v. Drug Enforcement Administration, Respondent.the National Organization for the Reform of Marijuana Laws, Petitioner, v. Drug Enforcement Administration, Respondent :: US Court of Appeals Cases :: Justia". Cases.justia.com. Retrieved 2011-04-20.